open.spotify.com
Mar 17, 2026, 15:43
How Clinicians Navigate the Challenge of Balancing Clotting and Bleeding in CAD – Vasculearn Network
Vasculearn Network shared a post on LinkedIn:
“Antithrombotic therapy in coronary artery disease isn’t one-size-fits-all anymore.
Heather M. Johnson, Ty J. Gluckman and Davide Capodanno come together in the latest episode of Clot, Clot, Who’s There? to chat about how clinicians are navigating the everyday challenge of balancing clotting and bleeding risk.
From the evolving role of aspirin to P2Y12 monotherapy, dual pathway inhibition, and managing CAD with AFib, the conversation highlights a simple shift in thinking:
Less of ‘What should everyone get?’
More of ‘What’s right for the patient in front of me?’
Stay updated with Hemostasis Today.
-
Oct 10, 2026, 02:17Dino Mehic: Managing Heavy Menstrual Bleeding in Patients with BDUC
-
Oct 10, 2026, 00:34Raphaëlle Dodart: Discussing the Mechanisms of Menstrual Hemostasis
-
Oct 10, 2026, 00:26Barbara Adams Krolak: Discussing the Growing Need for Blood Clot Prevention in Asia
-
Oct 9, 2026, 23:59Ana Pedrero Gil: Is Coagulopathy with Fibrinolysis Present in All Obstetric Hemorrhages?
-
Oct 9, 2026, 23:57Exploring the Psychosocial Needs of People with Bleeding Disorders in Kyrgyzstan – EAHAD
-
Oct 9, 2026, 23:53Bernard Slater Jr.: Serving on the Advisory Council for the NBDF West Virginia Chapter
-
Oct 9, 2026, 23:53Aurelio Maggio: Thalassemia Reports Real-Time Impact Factor Rises to 1.760
-
Oct 9, 2026, 23:52Stronger Connections, Stronger Organizations – World Federation of Hemophilia
-
Oct 9, 2026, 23:46Samuel Misiani Mbunya: Advancing Sickle Cell Care Through Collaboration at the 21st ASCAT Conference